Sphera Funds Management Ltd. 4 D Molecular Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.81 - $27.22 $2.1 Million - $5.28 Million	-193,824 Reduced 79.92%	48,702 $526,000
Q2 2024 Aug 14, 2024	BUY	$20.93 - $30.01 $1.68 Million - $2.41 Million	80,365 Added 49.56%	242,526 $5.09 Million
Q1 2024 May 15, 2024	BUY	$17.03 - $35.87 $2.76 Million - $5.82 Million	162,161 New	162,161 $5.17 Million

147

46.7M

121K

33.2K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $129M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.